ID

31669

Description

Efficacy and Safety Study of Cetuximab or Cetuximab Plus Docetaxel to Treat Prostate Cancer Before Prostatectomy; ODM derived from: https://clinicaltrials.gov/show/NCT00448097

Link

https://clinicaltrials.gov/show/NCT00448097

Keywords

Versions (1)
  1. 9/19/18 9/19/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 19, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Prostatic Neoplasms NCT00448097

English

Eligibility Prostatic Neoplasms NCT00448097

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic proof of prostatic adenocarcinoma without evidence of regional and/or distant metastasis, clinical stage t1c or t2a with high grade disease (gleason's 8-10) on initial biopsy, or clinical stage t2b-t2c with gleason's grade 7 or above with a psa ≥ 10ng/ml, or clinical stage t3.
Description

Adenocarcinoma of prostate | Neoplasm Metastasis regional Absent | Distant metastasis Absent | TNM clinical staging | Disease Severe Gleason score Biopsy | Gleason score | Prostate specific antigen measurement

Data type

boolean

Alias
UMLS CUI [1]
C0007112
UMLS CUI [2,1]
C0027627
UMLS CUI [2,2]
C0205147
UMLS CUI [2,3]
C0332197
UMLS CUI [3,1]
C1269798
UMLS CUI [3,2]
C0332197
UMLS CUI [4]
C3258246
UMLS CUI [5,1]
C0012634
UMLS CUI [5,2]
C0205082
UMLS CUI [5,3]
C3203027
UMLS CUI [5,4]
C0005558
UMLS CUI [6]
C3203027
UMLS CUI [7]
C0201544
recent (< 6 weeks prior to study entry) negative bone scan and mri of abdomen and pelvis.
Description

Abdomen Bone scan Negative | Pelvis Bone scan Negative | MRI of abdomen and pelvis Negative

Data type

boolean

Alias
UMLS CUI [1,1]
C0000726
UMLS CUI [1,2]
C0203668
UMLS CUI [1,3]
C1513916
UMLS CUI [2,1]
C0030797
UMLS CUI [2,2]
C0203668
UMLS CUI [2,3]
C1513916
UMLS CUI [3,1]
C1631605
UMLS CUI [3,2]
C1513916
appropriate surgical candidate for radical prostatectomy and a performance status of < 2 (zubrod scale).
Description

Patient Appropriate Radical prostatectomy | Zubrod Performance Status

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548787
UMLS CUI [1,3]
C0194810
UMLS CUI [2]
C3714786
patients should have adequate bone marrow function defined as an absolute peripheral granulocyte count > 1,500 and platelet count of > 100,000, adequate hepatic function with a bilirubin < 1.5 mg % and sgpt < 2.5x the upper limits of normal, adequate renal function defined as serum creatinine < 1.5 x uln.
Description

Bone Marrow function | Absolute neutrophil count Peripheral blood | Platelet Count measurement | Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Renal function | Creatinine measurement, serum

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2,1]
C0948762
UMLS CUI [2,2]
C0229664
UMLS CUI [3]
C0032181
UMLS CUI [4]
C0232741
UMLS CUI [5]
C1278039
UMLS CUI [6]
C0201836
UMLS CUI [7]
C0232804
UMLS CUI [8]
C0201976
patients must have normal coagulation profile (pt, ptt) and no history of substantial non-iatrogenic bleeding diatheses. use of anticoagulants is limited to local use only (for control of central line patency).
Description

Coagulation profile Normal | Prothrombin time assay | Activated Partial Thromboplastin Time measurement | Bleeding tendency Absent | Anticoagulants Local | Control Patency of Central line

Data type

boolean

Alias
UMLS CUI [1,1]
C0005790
UMLS CUI [1,2]
C0205307
UMLS CUI [2]
C0033707
UMLS CUI [3]
C0030605
UMLS CUI [4,1]
C1458140
UMLS CUI [4,2]
C0332197
UMLS CUI [5,1]
C0003280
UMLS CUI [5,2]
C0205276
UMLS CUI [6,1]
C2587213
UMLS CUI [6,2]
C0175566
UMLS CUI [6,3]
C1145640
patients must have no history of congestive heart failure or previous mi within the last 12 months.
Description

Congestive heart failure Absent | Myocardial Infarction Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0018802
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C0027051
UMLS CUI [2,2]
C0332197
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
previous or current hormonal treatment, chemotherapy, radiation therapy, immunotherapy or other investigational status drug.
Description

Hormone Therapy | Chemotherapy | Therapeutic radiology procedure | Immunotherapy | Investigational New Drugs

Data type

boolean

Alias
UMLS CUI [1]
C0279025
UMLS CUI [2]
C0392920
UMLS CUI [3]
C1522449
UMLS CUI [4]
C0021083
UMLS CUI [5]
C0013230
unable to tolerate transrectal ultrasound.
Description

Transrectal ultrasound Receive Unable

Data type

boolean

Alias
UMLS CUI [1,1]
C0373345
UMLS CUI [1,2]
C1514756
UMLS CUI [1,3]
C1299582
patients who are not appropriate surgical candidates for radical prostatectomy based on the evaluation of co-existent medical diseases and competing causes of death. patients with uncontrolled cardiac, hepatic, renal or neurologic/psychiatric disorder are not eligible. patients with uncontrolled and symptomatic orthostatic hypotension or uncontrolled hypertension are not eligible.
Description

Patients Inappropriate Radical prostatectomy | Comorbidity Evaluation | Heart Disease Uncontrolled | Liver disease Uncontrolled | Kidney Disease Uncontrolled | Nervous system disorder Uncontrolled | Mental disorders Uncontrolled | Hypotension orthostatic symptomatic Uncontrolled | Uncontrolled hypertension

Data type

boolean

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C1548788
UMLS CUI [1,3]
C0194810
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C1261322
UMLS CUI [3,1]
C0018799
UMLS CUI [3,2]
C0205318
UMLS CUI [4,1]
C0023895
UMLS CUI [4,2]
C0205318
UMLS CUI [5,1]
C0022658
UMLS CUI [5,2]
C0205318
UMLS CUI [6,1]
C0027765
UMLS CUI [6,2]
C0205318
UMLS CUI [7,1]
C0004936
UMLS CUI [7,2]
C0205318
UMLS CUI [8,1]
C0740482
UMLS CUI [8,2]
C0205318
UMLS CUI [9]
C1868885
patients who are hiv positive or have chronic hepatitis b or c infections are not eligible.
Description

HIV Seropositivity | Hepatitis B, Chronic | Hepatitis C, Chronic

Data type

boolean

Alias
UMLS CUI [1]
C0019699
UMLS CUI [2]
C0524909
UMLS CUI [3]
C0524910
patients on oral steroid medications are not eligible.
Description

Steroids Oral

Data type

boolean

Alias
UMLS CUI [1,1]
C0038317
UMLS CUI [1,2]
C1527415
patients with significant arteriosclerotic disease, as defined by a previous arterial bypass claudication limiting activity, or a history of cerebrovascular events within the last year (including tia) are not eligible.
Description

Arteriosclerosis | Artery Bypass | Claudication Limiting Activity | Event Cerebrovascular | Transient Ischemic Attack

Data type

boolean

Alias
UMLS CUI [1]
C0003850
UMLS CUI [2,1]
C0003842
UMLS CUI [2,2]
C0741847
UMLS CUI [3,1]
C1456822
UMLS CUI [3,2]
C0439801
UMLS CUI [3,3]
C0026606
UMLS CUI [4,1]
C0441471
UMLS CUI [4,2]
C1880018
UMLS CUI [5]
C0007787
prior severe infusion reaction to a monoclonal antibody.
Description

Infusion reaction Severe Monoclonal Antibody

Data type

boolean

Alias
UMLS CUI [1,1]
C2368034
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0003250
Back to the top of the page

Similar models

Eligibility Prostatic Neoplasms NCT00448097

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Adenocarcinoma of prostate | Neoplasm Metastasis regional Absent | Distant metastasis Absent | TNM clinical staging | Disease Severe Gleason score Biopsy | Gleason score | Prostate specific antigen measurement
Item
histologic proof of prostatic adenocarcinoma without evidence of regional and/or distant metastasis, clinical stage t1c or t2a with high grade disease (gleason's 8-10) on initial biopsy, or clinical stage t2b-t2c with gleason's grade 7 or above with a psa ≥ 10ng/ml, or clinical stage t3.
boolean
C0007112 (UMLS CUI [1])
C0027627 (UMLS CUI [2,1])
C0205147 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
C1269798 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C3258246 (UMLS CUI [4])
C0012634 (UMLS CUI [5,1])
C0205082 (UMLS CUI [5,2])
C3203027 (UMLS CUI [5,3])
C0005558 (UMLS CUI [5,4])
C3203027 (UMLS CUI [6])
C0201544 (UMLS CUI [7])
Abdomen Bone scan Negative | Pelvis Bone scan Negative | MRI of abdomen and pelvis Negative
Item
recent (< 6 weeks prior to study entry) negative bone scan and mri of abdomen and pelvis.
boolean
C0000726 (UMLS CUI [1,1])
C0203668 (UMLS CUI [1,2])
C1513916 (UMLS CUI [1,3])
C0030797 (UMLS CUI [2,1])
C0203668 (UMLS CUI [2,2])
C1513916 (UMLS CUI [2,3])
C1631605 (UMLS CUI [3,1])
C1513916 (UMLS CUI [3,2])
Patient Appropriate Radical prostatectomy | Zubrod Performance Status
Item
appropriate surgical candidate for radical prostatectomy and a performance status of < 2 (zubrod scale).
boolean
C0030705 (UMLS CUI [1,1])
C1548787 (UMLS CUI [1,2])
C0194810 (UMLS CUI [1,3])
C3714786 (UMLS CUI [2])
Bone Marrow function | Absolute neutrophil count Peripheral blood | Platelet Count measurement | Liver function | Serum total bilirubin measurement | Alanine aminotransferase measurement | Renal function | Creatinine measurement, serum
Item
patients should have adequate bone marrow function defined as an absolute peripheral granulocyte count > 1,500 and platelet count of > 100,000, adequate hepatic function with a bilirubin < 1.5 mg % and sgpt < 2.5x the upper limits of normal, adequate renal function defined as serum creatinine < 1.5 x uln.
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0948762 (UMLS CUI [2,1])
C0229664 (UMLS CUI [2,2])
C0032181 (UMLS CUI [3])
C0232741 (UMLS CUI [4])
C1278039 (UMLS CUI [5])
C0201836 (UMLS CUI [6])
C0232804 (UMLS CUI [7])
C0201976 (UMLS CUI [8])
Coagulation profile Normal | Prothrombin time assay | Activated Partial Thromboplastin Time measurement | Bleeding tendency Absent | Anticoagulants Local | Control Patency of Central line
Item
patients must have normal coagulation profile (pt, ptt) and no history of substantial non-iatrogenic bleeding diatheses. use of anticoagulants is limited to local use only (for control of central line patency).
boolean
C0005790 (UMLS CUI [1,1])
C0205307 (UMLS CUI [1,2])
C0033707 (UMLS CUI [2])
C0030605 (UMLS CUI [3])
C1458140 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C0003280 (UMLS CUI [5,1])
C0205276 (UMLS CUI [5,2])
C2587213 (UMLS CUI [6,1])
C0175566 (UMLS CUI [6,2])
C1145640 (UMLS CUI [6,3])
Congestive heart failure Absent | Myocardial Infarction Absent
Item
patients must have no history of congestive heart failure or previous mi within the last 12 months.
boolean
C0018802 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C0027051 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
Item Group
C0680251 (UMLS CUI)
Hormone Therapy | Chemotherapy | Therapeutic radiology procedure | Immunotherapy | Investigational New Drugs
Item
previous or current hormonal treatment, chemotherapy, radiation therapy, immunotherapy or other investigational status drug.
boolean
C0279025 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0021083 (UMLS CUI [4])
C0013230 (UMLS CUI [5])
Transrectal ultrasound Receive Unable
Item
unable to tolerate transrectal ultrasound.
boolean
C0373345 (UMLS CUI [1,1])
C1514756 (UMLS CUI [1,2])
C1299582 (UMLS CUI [1,3])
Patients Inappropriate Radical prostatectomy | Comorbidity Evaluation | Heart Disease Uncontrolled | Liver disease Uncontrolled | Kidney Disease Uncontrolled | Nervous system disorder Uncontrolled | Mental disorders Uncontrolled | Hypotension orthostatic symptomatic Uncontrolled | Uncontrolled hypertension
Item
patients who are not appropriate surgical candidates for radical prostatectomy based on the evaluation of co-existent medical diseases and competing causes of death. patients with uncontrolled cardiac, hepatic, renal or neurologic/psychiatric disorder are not eligible. patients with uncontrolled and symptomatic orthostatic hypotension or uncontrolled hypertension are not eligible.
boolean
C0030705 (UMLS CUI [1,1])
C1548788 (UMLS CUI [1,2])
C0194810 (UMLS CUI [1,3])
C0009488 (UMLS CUI [2,1])
C1261322 (UMLS CUI [2,2])
C0018799 (UMLS CUI [3,1])
C0205318 (UMLS CUI [3,2])
C0023895 (UMLS CUI [4,1])
C0205318 (UMLS CUI [4,2])
C0022658 (UMLS CUI [5,1])
C0205318 (UMLS CUI [5,2])
C0027765 (UMLS CUI [6,1])
C0205318 (UMLS CUI [6,2])
C0004936 (UMLS CUI [7,1])
C0205318 (UMLS CUI [7,2])
C0740482 (UMLS CUI [8,1])
C0205318 (UMLS CUI [8,2])
C1868885 (UMLS CUI [9])
HIV Seropositivity | Hepatitis B, Chronic | Hepatitis C, Chronic
Item
patients who are hiv positive or have chronic hepatitis b or c infections are not eligible.
boolean
C0019699 (UMLS CUI [1])
C0524909 (UMLS CUI [2])
C0524910 (UMLS CUI [3])
Steroids Oral
Item
patients on oral steroid medications are not eligible.
boolean
C0038317 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
Arteriosclerosis | Artery Bypass | Claudication Limiting Activity | Event Cerebrovascular | Transient Ischemic Attack
Item
patients with significant arteriosclerotic disease, as defined by a previous arterial bypass claudication limiting activity, or a history of cerebrovascular events within the last year (including tia) are not eligible.
boolean
C0003850 (UMLS CUI [1])
C0003842 (UMLS CUI [2,1])
C0741847 (UMLS CUI [2,2])
C1456822 (UMLS CUI [3,1])
C0439801 (UMLS CUI [3,2])
C0026606 (UMLS CUI [3,3])
C0441471 (UMLS CUI [4,1])
C1880018 (UMLS CUI [4,2])
C0007787 (UMLS CUI [5])
Infusion reaction Severe Monoclonal Antibody
Item
prior severe infusion reaction to a monoclonal antibody.
boolean
C2368034 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0003250 (UMLS CUI [1,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial